Hormonal dysregulation and gut microbiota alterations as potential contributors to cognitive dysfunction CHINA, March ...

Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3 in Q3 2026CARMEL, Ind., March 09, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage ...

Thyroid disorders, polycystic ovary syndrome (PCOS), autoimmune diseases, osteoporosis, and iron deficiency anaemia are some of the health conditions that affect women more than men.

Approved dosing regimen reduces the burden for eligible patients, their families, and the broader healthcare system by ...

Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...